🇺🇸 PFE — Pfizer Inc.

Salud Compra
← Volver

Precio actual

29,39 USD

Máx. histórico

61,25

1786 días

Split 1054:1000 del 17/11/2020

Caída desde máximo

-52,02%

Rango 52 semanas

23,62 – 31,44

Variación hoy

-0,20%

Cierre anterior

29,88

Rango de hoy

28,54 – 29,43

Volumen hoy

48.232.765

Peor caída histórica

-69,25%

12/04/1999 → 02/03/2009

Recuperado en 1717 días

Volatilidad anualizada ⓘ

27,33%

Información
Nombre completo
Pfizer Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
75.000
PER ⓘ
41,99 (puede no estar actualizado)
Dividend yield
5,76% (puede no estar actualizado)
Precio objetivo analistas
29,72 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 2 días
Sobre la empresa

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Dividendos repartidos Total últimos 12 meses: 1,2900 USD · Yield: 4,39%
Fecha de pago Importe por participación
31/01/2019 0,3416 USD
08/11/2018 0,3226 USD
02/08/2018 0,3226 USD
10/05/2018 0,3226 USD
01/02/2018 0,3226 USD
09/11/2017 0,3036 USD
02/08/2017 0,3036 USD
10/05/2017 0,3036 USD
01/02/2017 0,3036 USD
08/11/2016 0,2846 USD
03/08/2016 0,2846 USD
11/05/2016 0,2846 USD
03/02/2016 0,2846 USD
04/11/2015 0,2657 USD
05/08/2015 0,2657 USD
Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2020 1054:1000
01/07/1999 3:1
01/07/1997 2:1
03/07/1995 2:1
01/04/1991 2:1
01/07/1983 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
07/02/1977 0,53 0,54 0,53 0,53 +0,00% 1,86% 5.352.634
04/02/1977 0,53 0,54 0,53 0,53 +0,00% 1,86% 4.598.813
03/02/1977 0,54 0,54 0,52 0,53 -1,83% 3,66% 3.192.355
02/02/1977 0,54 0,55 0,54 0,54 +0,00% 1,83% 3.131.645
01/02/1977 0,53 0,54 0,53 0,54 +1,86% 1,86% 4.017.005
31/01/1977 0,53 0,54 0,53 0,53 +0,00% 1,86% 4.902.365
28/01/1977 0,52 0,53 0,51 0,53 +1,90% 3,80% 3.313.776
27/01/1977 0,52 0,52 0,51 0,52 +0,00% 1,90% 2.301.936
26/01/1977 0,52 0,53 0,52 0,52 +0,00% 1,90% 1.811.194
25/01/1977 0,53 0,53 0,52 0,52 -1,86% 1,86% 2.514.422
24/01/1977 0,54 0,54 0,52 0,53 -1,83% 3,66% 2.706.672
21/01/1977 0,52 0,54 0,52 0,54 +3,80% 3,80% 2.671.258
20/01/1977 0,53 0,54 0,52 0,52 -1,86% 3,73% 2.580.192
19/01/1977 0,53 0,54 0,53 0,53 +0,00% 1,86% 2.949.514
18/01/1977 0,55 0,55 0,53 0,53 -3,59% 3,59% 2.549.837
17/01/1977 0,55 0,55 0,54 0,55 +0,00% 1,80% 1.517.760
14/01/1977 0,56 0,56 0,54 0,55 -1,77% 3,53% 2.013.562
13/01/1977 0,56 0,57 0,56 0,56 +0,00% 1,32% 1.618.944
12/01/1977 0,57 0,57 0,56 0,56 -1,30% 1,30% 1.912.378
11/01/1977 0,56 0,57 0,56 0,57 +1,32% 1,32% 1.421.635
10/01/1977 0,56 0,57 0,56 0,56 +0,00% 1,32% 1.816.253
07/01/1977 0,56 0,57 0,56 0,56 +0,00% 1,32% 1.244.563
06/01/1977 0,55 0,57 0,55 0,56 +1,80% 3,14% 1.244.563
05/01/1977 0,56 0,56 0,54 0,55 -1,77% 3,53% 2.084.390
04/01/1977 0,57 0,57 0,56 0,56 -1,30% 1,30% 1.882.022
03/01/1977 0,58 0,58 0,57 0,57 -1,71% 1,71% 2.210.870
31/12/1976 0,57 0,58 0,57 0,58 +1,74% 1,74% 3.187.296
30/12/1976 0,56 0,57 0,56 0,57 +1,32% 1,32% 2.737.027
29/12/1976 0,56 0,57 0,55 0,56 +0,00% 3,08% 2.681.376
28/12/1976 0,55 0,56 0,55 0,56 +1,80% 1,80% 3.005.165